p53 and Cell Cycle Dependent Transcription of kinesin family member 23 (KIF23) Is Controlled Via a CHR Promoter Element Bound by DREAM and MMB Complexes

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Fischer, Martin ^a   Grundke, Inga ^a   Sohr, Sindy ^a   Quaas, Marianne ^a   Hoffmann, Saskia ^a,c   Knörck, Arne ^b   Gumhold, Catalina ^b   Rother, Karen ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALSENILIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; KINESIN FAMILY MEMBER 23; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MMB; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ISOPROTEIN; KCNIP3 PROTEIN, HUMAN; KIF23 PROTEIN, HUMAN; KV CHANNEL INTERACTING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; PROTEIN BINDING; REPRESSOR PROTEIN; TP53 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE GENE HOMOLOGY REGION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINESIS; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENETIC CONSERVATION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIF23 GENE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; 3T3 CELL LINE; ANIMAL; CELL CYCLE; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HCT116 CELL LINE; METABOLISM; MOUSE; PROTEIN STABILITY;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; GENE SILENCING; HCT116 CELLS; HUMANS; KV CHANNEL-INTERACTING PROTEINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NIH 3T3 CELLS; ONCOGENE PROTEINS V-MYB; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STABILITY; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877019730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063187     Document Type: Article

References (64)

1. Schuldt A, (2010) Cytoskeleton: midzone microtubule management. Nat Rev Mol Cell Biol 11: 602-603 nrm2965 [pii];10.1038/nrm2965 [doi].
2. Pavicic-Kaltenbrunner V, Mishima M, Glotzer M, (2007) Cooperative assembly of CYK-4/MgcRacGAP and ZEN-4/MKLP1 to form the centralspindlin complex. Mol Biol Cell 18: 4992-5003 E07-05-0468 [pii];10.1091/mbc.E07-05-0468 [doi].
3. Hutterer A, Glotzer M, Mishima M, (2009) Clustering of centralspindlin is essential for its accumulation to the central spindle and the midbody. Curr Biol 19: 2043-2049 S0960-9822(09)01912-5 [pii];10.1016/j.cub.2009.10.050 [doi].
4. Nislow C, Lombillo VA, Kuriyama R, McIntosh JR, (1992) A plus-end-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindles. Nature 359: 543-547 10.1038/359543a0 [doi].
5. Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, et al. (2012) Downregulation of KIF23 suppresses glioma proliferation. J Neurooncol 106: 519-529 10.1007/s11060-011-0706-2 [doi].
6. Seguin L, Liot C, Mzali R, Harada R, Siret A, et al. (2009) CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase. Mol Cell Biol 29: 570-581 MCB.01275-08 [pii];10.1128/MCB.01275-08 [doi].
7. Müller GA, Engeland K, (2010) The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription. FEBS J 277: 877-893 EJB7508 [pii];10.1111/j.1742-4658.2009.07508.x [doi].
8. Müller GA, Quaas M, Schumann M, Krause E, Padi M, et al. (2012) The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucleic Acids Res 40: 1561-1578 gkr793 [pii];10.1093/nar/gkr793 [doi].
9. Korenjak M, Taylor-Harding B, Binne UK, Satterlee JS, Stevaux O, et al. (2004) Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119: 181-193 S0092867404009377 [pii];10.1016/j.cell.2004.09.034 [doi].
10. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, et al. (2007) Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26: 539-551 S1097-2765(07)00251-1 [pii];10.1016/j.molcel.2007.04.015 [doi].
11. Schmit F, Korenjak M, Mannefeld M, Schmitt K, Franke C, et al. (2007) LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes. Cell Cycle 6: 1903-1913. 4512 [pii].
12. Knight AS, Notaridou M, Watson RJ, (2009) A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells. Oncogene 28: 1737-1747 onc200922 [pii];10.1038/onc.2009.22 [doi].
13. Osterloh L, von EB, Schmit F, Rein L, Hubner D, et al. (2007) The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis. EMBO J 26: 144-157 7601478 [pii];10.1038/sj.emboj.7601478 [doi].
14. Pilkinton M, Sandoval R, Colamonici OR, (2007) Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex. Oncogene 26: 7535-7543 1210562 [pii];10.1038/sj.onc.1210562 [doi].
15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW, (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311.
16. Hammond EM, Giaccia AJ, (2005) The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331: 718-725 S0006-291X(05)00660-1 [pii];10.1016/j.bbrc.2005.03.154 [doi].
17. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210 10.1038/35018127 [doi].
18. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825. 0092-8674(93)90500-P [pii].
19. Spurgers KB, Gold DL, Coombes KR, Bohnenstiehl NL, Mullins B, et al. (2006) Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem 281: 25134-25142.
20. Böhlig L, Rother K, (2011) One function-multiple mechanisms: the manifold activities of p53 as a transcriptional repressor. J Biomed Biotechnol 2011: 464916 10.1155/2011/464916 [doi].
21. Van BD, Roessingh W, Pridjian A, El Dahr SS, (2010) Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter. Biochim Biophys Acta 1799: 502-509.
22. Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, et al. (2006) Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. Biochem J 400: 303-313.
23. Pietrzak M, Puzianowska-Kuznicka M (2008) p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol Chem.
24. Basile V, Mantovani R, Imbriano C, (2006) DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines. J Biol Chem 281: 2347-2357.
25. Esteve PO, Chin HG, Pradhan S, (2005) Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci U S A 102: 1000-1005.
26. Lohr K, Moritz C, Contente A, Dobbelstein M, (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 278: 32507-32516.
27. Scian MJ, Carchman EH, Mohanraj L, Stagliano KE, Anderson MA, et al. (2007) Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Oncogene.
28. Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, et al. (2004) p53-dependent down-regulation of telomerase is mediated by p21waf1. J Biol Chem 279: 50976-50985.
29. Quaas M, Muller GA, Engeland K, (2012) p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements. Cell Cycle 11: 4661-4672 22917 [pii];10.4161/cc.22917 [doi].
30. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
31. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, et al. (1999) Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A 96: 14517-14522.
32. Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, et al. (2000) The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28: 4410-4418.
33. Sohr S, Engeland K, (2008) RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53. Cell Cycle 7: 3448-3460.
34. Tavner F, Frampton J, Watson RJ, (2007) Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Oncogene 26: 2727-2735 1210087 [pii];10.1038/sj.onc.1210087 [doi].
35. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B, (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915.
36. Sohr S, Engeland K, (2011) The tumor suppressor p53 induces expression of the pregnancy-supporting human chorionic gonadotropin (hCG) CGB7 gene. Cell Cycle 10: 3758-3767 17946 [pii];10.4161/cc.10.21.17946 [doi].
37. Böhlig L, Friedrich M, Engeland K (2010) p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res. gkq796 [pii];10.1093/nar/gkq796 [doi].
38. Kuriyama R, Gustus C, Terada Y, Uetake Y, Matuliene J, (2002) CHO1, a mammalian kinesin-like protein, interacts with F-actin and is involved in the terminal phase of cytokinesis. J Cell Biol 156: 783-790 10.1083/jcb.200109090 [doi];jcb.200109090 [pii].
39. Lavin MF, Gueven N, (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13: 941-950 4401925 [pii];10.1038/sj.cdd.4401925 [doi].
40. Neef R, Klein UR, Kopajtich R, Barr FA, (2006) Cooperation between mitotic kinesins controls the late stages of cytokinesis. Curr Biol 16: 301-307 S0960-9822(05)01592-7 [pii];10.1016/j.cub.2005.12.030 [doi].
41. Wasner M, Haugwitz U, Reinhard W, Tschop K, Spiesbach K, et al. (2003) Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter. Gene 312: 225-237. S0378111903006188 [pii].
42. Dolfini D, Gatta R, Mantovani R, (2012) NF-Y and the transcriptional activation of CCAAT promoters. Crit Rev Biochem Mol Biol 47: 29-49 10.3109/10409238.2011.628970 [doi].
43. Fukasawa K, (2008) P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochim Biophys Acta 1786: 15-23 S0304-419X(08)00022-X [pii];10.1016/j.bbcan.2008.04.002 [doi].
44. Valk K, Vooder T, Kolde R, Reintam MA, Petzold C, et al. (2010) Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology 79: 283-292 000322116 [pii];10.1159/000322116 [doi].
45. Wang SM, Ooi LL, Hui KM, (2011) Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res 17: 6040-6051 1078-0432.CCR-11-0557 [pii];10.1158/1078-0432.CCR-11-0557 [doi].
46. Mukhina S, Wang YL, Murata-Hori M, (2007) Alpha-actinin is required for tightly regulated remodeling of the actin cortical network during cytokinesis. Dev Cell 13: 554-565 S1534-5807(07)00303-6 [pii];10.1016/j.devcel.2007.08.003 [doi].
47. Imbriano C, Gnesutta N, Mantovani R, (2012) The NF-Y/p53 liaison: Well beyond repression. Biochim Biophys Acta 1825: 131-139 S0304-419X(11)00065-5 [pii];10.1016/j.bbcan.2011.11.001 [doi].
48. Riley T, Sontag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
49. Barboza JA, Liu G, Ju Z, El-Naggar AK, Lozano G, (2006) p21 delays tumor onset by preservation of chromosomal stability. Proc Natl Acad Sci U S A 103: 19842-19847 0606343104 [pii];10.1073/pnas.0606343104 [doi].
50. Helmbold H, Komm N, Deppert W, Bohn W, (2009) Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene 28: 3456-3467 onc2009222 [pii];10.1038/onc.2009.222 [doi].
51. Jackson MW, Agarwal MK, Yang J, Bruss P, Uchiumi T, et al. (2005) p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. J Cell Sci 118: 1821-1832.
52. Bashir T, Pagano M, (2005) Cdk1: the dominant sibling of Cdk2. Nat Cell Biol 7: 779-781 ncb0805-779 [pii];10.1038/ncb0805-77910.1038/ncb0805-779 [doi].
53. Tedesco D, Lukas J, Reed SI, (2002) The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 16: 2946-2957 10.1101/gad.1011202 [doi].
54. Calvisi DF, Simile MM, Ladu S, Frau M, Evert M, et al. (2011) Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. Hepatology 53: 1226-1236 10.1002/hep.24174 [doi].
55. Mannefeld M, Klassen E, Gaubatz S, (2009) B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells. Cancer Res 69: 4073-4080.
56. Botcheva K, McCorkle SR, McCombie WR, Dunn JJ, Anderson CW, (2011) Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle 10: 4237-4249 18383 [pii];10.4161/cc.10.24.18383 [doi].
57. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, et al. (2008) Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 36: 3639-3654 gkn232 [pii];10.1093/nar/gkn232 [doi].
58. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, et al. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207-219 S0092-8674(05)01399-1 [pii];10.1016/j.cell.2005.10.043 [doi].
59. Sadasivam S, Duan S, DeCaprio JA, (2012) The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev 26: 474-489 26/5/474 [pii];10.1101/gad.181933.111 [doi].
60. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166 nrc2602 [pii];10.1038/nrc2602 [doi].
61. Saville MK, Watson RJ, (1998) The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene 17: 2679-2689 10.1038/sj.onc.1202503 [doi].
62. Chen X, Muller GA, Quaas M, Fischer M, Han N, et al. (2013) The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism. Mol Cell Biol 33: 227-236 MCB.00881-12 [pii];10.1128/MCB.00881-12 [doi].
63. Pilkinton M, Sandoval R, Song J, Ness SA, Colamonici OR, (2007) Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1. J Biol Chem 282: 168-175 M609924200 [pii];10.1074/jbc.M609924200 [doi].
64. Reichert N, Wurster S, Ulrich T, Schmitt K, Hauser S, et al. (2010) Lin9, a subunit of the mammalian DREAM complex, is essential for embryonic development, for survival of adult mice, and for tumor suppression. Mol Cell Biol 30: 2896-2908 MCB.00028-10 [pii];10.1128/MCB.00028-10 [doi].